Breaking News

Has no content to show!

Pharmaceutical News

Aurobindo launches $1.6 billion bid to buy Novartis generics unit

Aurobindo Pharma Ltd has submitted an initial bid to buy Novartis AG’s dermatology generics drug business for about $1.6 billion, two people directly aware of the development said on condition of anonymity.


Sun Pharma Q3 profit falls 75% to Rs 365 cr on tax cost; operating income tanks 41%

Sun Pharma's third quarter earnings disappointed analysts on Wednesday as profit fell sharply by 75.2 percent to Rs 365.4 crore, dragged by exceptional tax expenses.


Govt stalls plan to cut drug prices after pushback from pharma companies

India’s proposal to curb drug prices by stripping generic medicines of their brand names has stalled after the plan faced pushback from the country’s pharmaceutical companies, according to people with knowledge of the discussions.


Sun Pharma’s Halol facility gets clearance from Dutch drug regulator

Sun Pharma, the largest pharma company by revenue and market share in India, has received a clearance for its Halol facility from a Dutch drug regulator on January 10, 2018.


About Us

Wealthbuilder.co.in is design and developed to provide quality trading and investment recommendations & guidance for trading in the Indian Stock Market.

Wealthbuilder.co.in attempts to deliver a value driven service to the investing community by bringing together a powerful mix of expert advice, stock news and analysis.

Contact Information


Brand Partners